{"disease":{"id":"transhumeral-amputation","name":"transhumeral amputation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT06853938","title":"Optimizing Transhumeral Osseointegration Prosthesis Control","phase":"NA","overall_status":"RECRUITING","enrollment_count":5,"lead_sponsor_name":"University of Alberta","has_results":false},{"nct_id":"NCT03824444","title":"EFS Functional Expectations of Transhumeral Percutaneous OI Patients","phase":"EARLY_PHASE1","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"VA Office of Research and Development","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}